PMID- 28268194 OWN - NLM STAT- MEDLINE DCOM- 20170915 LR - 20180321 IS - 1872-7905 (Electronic) IS - 0022-1759 (Linking) VI - 447 DP - 2017 Aug TI - A bioluminescent caspase-1 activity assay rapidly monitors inflammasome activation in cells. PG - 1-13 LID - S0022-1759(16)30275-7 [pii] LID - 10.1016/j.jim.2017.03.004 [doi] AB - Inflammasomes are protein complexes induced by diverse inflammatory stimuli that activate caspase-1, resulting in the processing and release of cytokines, IL-1beta and IL-18, and pyroptosis, an immunogenic form of cell death. To provide a homogeneous method for detecting caspase-1 activity, we developed a bioluminescent, plate-based assay that combines a substrate, Z-WEHD-aminoluciferin, with a thermostable luciferase in an optimized lytic reagent added directly to cultured cells. Assay specificity for caspase-1 is conferred by inclusion of a proteasome inhibitor in the lytic reagent and by use of a caspase-1 inhibitor to confirm activity. This approach enables a specific and rapid determination of caspase-1 activation. Caspase-1 activity is stable in the reagent thereby providing assay convenience and flexibility. Using this assay system, caspase-1 activation has been determined in THP-1 cells following treatment with alpha-hemolysin, LPS, nigericin, gramicidin, MSU, R848, Pam3CSK4, and flagellin. Caspase-1 activation has also been demonstrated in treated J774A.1 mouse macrophages, bone marrow-derived macrophages (BMDMs) from mice, as well as in human primary monocytes. Caspase-1 activity was not detected in treated BMDMs derived from Casp1(-/-) mice, further confirming the specificity of the assay. Caspase-1 activity can be measured directly in cultured cells using the lytic reagent, or caspase-1 activity released into medium can be monitored by assay of transferred supernatant. The caspase-1 assay can be multiplexed with other assays to monitor additional parameters from the same cells, such as IL-1beta release or cell death. The caspase-1 assay in combination with a sensitive real-time monitor of cell death allows one to accurately establish pyroptosis. This assay system provides a rapid, convenient, and flexible method to specifically and quantitatively monitor caspase-1 activation in cells in a plate-based format. This will allow a more efficient and effective assessment of inflammasome activation as well as enable high-throughput screening for inflammasome modulators. CI - Copyright (c) 2017 The Authors. Published by Elsevier B.V. All rights reserved. FAU - O'Brien, Martha AU - O'Brien M AD - Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711, USA. Electronic address: martha.obrien@promega.com. FAU - Moehring, Danielle AU - Moehring D AD - Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711, USA. FAU - Munoz-Planillo, Raul AU - Munoz-Planillo R AD - Dept. of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. FAU - Nunez, Gabriel AU - Nunez G AD - Dept. of Pathology, University of Michigan Medical School, Ann Arbor, MI 48109, USA. FAU - Callaway, Justin AU - Callaway J AD - Dept. of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. FAU - Ting, Jenny AU - Ting J AD - Dept. of Microbiology and Immunology, School of Medicine, University of North Carolina, Chapel Hill, NC 27599, USA. FAU - Scurria, Mike AU - Scurria M AD - Promega Biosciences LLC, 277 Granada Dr, San Luis Obispo, CA 93401, USA. FAU - Ugo, Tim AU - Ugo T AD - Promega Biosciences LLC, 277 Granada Dr, San Luis Obispo, CA 93401, USA. FAU - Bernad, Laurent AU - Bernad L AD - Promega Biosciences LLC, 277 Granada Dr, San Luis Obispo, CA 93401, USA. FAU - Cali, James AU - Cali J AD - Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711, USA. FAU - Lazar, Dan AU - Lazar D AD - Promega Corporation, 2800 Woods Hollow Rd, Madison, WI 53711, USA. LA - eng PT - Journal Article DEP - 20170306 PL - Netherlands TA - J Immunol Methods JT - Journal of immunological methods JID - 1305440 RN - 0 (Inflammasomes) RN - EC 1.13.12.- (Luciferases) RN - EC 3.4.22.36 (Caspase 1) SB - IM MH - Animals MH - Caspase 1/*metabolism MH - Cell Line MH - Enzyme Activation MH - Humans MH - Inflammasomes/*metabolism MH - Luciferases/metabolism MH - Luminescent Measurements/instrumentation/*methods MH - Macrophages/drug effects/metabolism MH - Mice MH - Monocytes/enzymology/*metabolism MH - Pyroptosis MH - Sensitivity and Specificity OTO - NOTNLM OT - Bioluminescent OT - Caspase-1 assay OT - Inflammasome OT - Macrophages OT - Pyroptosis OT - THP-1 monocytes EDAT- 2017/03/08 06:00 MHDA- 2017/09/16 06:00 CRDT- 2017/03/08 06:00 PHST- 2016/10/21 00:00 [received] PHST- 2017/02/13 00:00 [revised] PHST- 2017/03/03 00:00 [accepted] PHST- 2017/03/08 06:00 [pubmed] PHST- 2017/09/16 06:00 [medline] PHST- 2017/03/08 06:00 [entrez] AID - S0022-1759(16)30275-7 [pii] AID - 10.1016/j.jim.2017.03.004 [doi] PST - ppublish SO - J Immunol Methods. 2017 Aug;447:1-13. doi: 10.1016/j.jim.2017.03.004. Epub 2017 Mar 6.